Antenatal Steroids: Saving Preterm Babies

Preterm birth, defined as delivery before 37 weeks of gestation, affects millions worldwide and remains a leading cause of neonatal mortality and morbidity. Antenatal corticosteroids, commonly referred to as antenatal steroids, represent one of the most effective pharmacological interventions to mitigate these risks. Administered to pregnant individuals at risk of imminent preterm delivery, these steroids accelerate fetal lung maturation, reducing the incidence of respiratory distress syndrome (RDS), intraventricular hemorrhage (IVH), and other severe complications.

The Science Behind Antenatal Steroids

Antenatal steroids work by crossing the placenta and stimulating the production of surfactant in the fetal lungs—a vital substance that prevents alveolar collapse after birth. This mechanism is particularly crucial for extremely preterm infants (born before 28 weeks), who face the highest risks of lung immaturity. Betamethasone, given as two intramuscular doses 24 hours apart, and dexamethasone, administered as four doses 12 hours apart, are the primary agents used globally.

Research from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) demonstrates that even a single dose of betamethasone, administered as little as hours before birth, yields measurable benefits. In a cohort of 1,806 infants born at 22-26 weeks, those exposed to one dose within 24 hours showed a 1% increase in survival and survival without major illness per hour of exposure time.

Proven Benefits in Diverse Settings

• Survival Boost: In high-resource environments, full courses reduce neonatal mortality by 30% and RDS by 40-50%.
• Low-Resource Efficacy: The WHO ACTION-I trial, involving 2,852 women across Bangladesh, India, Kenya, Nigeria, and Pakistan, found dexamethasone saved one preterm life for every 25 mothers treated, with no rise in maternal infections.
• Short-Course Advantages: Even partial exposure (under 24 hours) correlates with lower rates of necrotizing enterocolitis (NEC), IVH, and need for mechanical ventilation.

These outcomes underscore the steroids’ versatility, proving effective regardless of healthcare infrastructure when paired with basic neonatal care like thermal support, feeding assistance, and CPAP.

Optimal Timing and Gestational Windows

Ideal administration occurs 24-48 hours before delivery, allowing maximal fetal exposure. Benefits peak between 26-34 weeks gestation, where lung maturation is most responsive. Ultrasound-confirmed dating is essential to target this window accurately.

Data from multicenter studies confirm that for imminent births, initiating treatment proactively—even if incomplete—outweighs withholding it.

Administration Protocols and Dosage

Standard regimens prioritize betamethasone due to its longer half-life and established safety profile:

• Betamethasone: 12 mg IM, repeated after 24 hours (maximum 2 doses per course).
• Dexamethasone: 6 mg IM every 12 hours for 4 doses, favored in low-resource areas for cost and availability.

Repeat courses are generally discouraged unless over 7 days have passed since the initial treatment and preterm risk persists. Providers must weigh benefits against potential cumulative effects.

Potential Risks and Long-Term Considerations

While overwhelmingly beneficial, antenatal steroids are not without caveats. Approximately 40% of treated pregnancies result in term births, where exposure may link to subtle risks like neonatal intensive care admission, transient tachypnea, and growth restriction.

Longer-term data from animal models and observational studies raise concerns about brain growth and body size with repeated high doses, though human evidence remains mixed. Mistimed administration (e.g., >34 weeks or >1 week pre-delivery) may diminish benefits and introduce unnecessary exposure.

BMJ-published analyses of 1.6 million infants highlight the need for precise risk stratification to avoid overuse in low-risk cases.

Global Guidelines and Implementation Challenges

Leading bodies endorse universal use in threatened preterm labor before 34 weeks:

• WHO: Recommends dexamethasone in low-resource settings with basic newborn care.
• NICHD: Advocates single-dose betamethasone for imminent extremely preterm births.
• ACOG: Supports repeat courses only after 7 days if clinically indicated (inferred from cohort data).

Challenges include accurate gestational dating, drug availability, and ensuring postnatal support. In low-income regions, integrating steroids with resuscitation training amplifies impact.

Clinical Decision-Making Framework

Healthcare providers should assess:

1. Gestational age via ultrasound.
2. Preterm birth likelihood within 7 days.
3. Absence of contraindications (e.g., active infection, chorioamnionitis).
4. Facility capability for neonatal resuscitation.

For borderline cases, the risk-benefit tilts toward administration, as partial courses still confer advantages.

Frequently Asked Questions (FAQs)

What if my baby is born before completing the steroid course?

Partial courses, even single doses hours before birth, improve survival by 1% per exposure hour and reduce major morbidities.

Are antenatal steroids safe for the mother?

Yes, trials show no increased maternal infection risk, even in resource-limited settings.

Can steroids be repeated?

Only after 7 days; excessive repeats may pose neurodevelopmental risks.

Which steroid is better: betamethasone or dexamethasone?

Betamethasone for high-resource optimal outcomes; dexamethasone for affordability in low-resource areas.

Do steroids work after 34 weeks?

Benefits wane; routine use beyond 34 weeks is not recommended due to potential term-birth risks.

Future Directions in Research

Ongoing trials explore optimal repeat dosing, long-term neurodevelopment, and alternatives like synthetic surfactants. Cohort studies continue refining time-dependent benefits for extreme preterm cases. Personalized approaches, factoring genetics and maternal health, may further enhance precision.

In summary, antenatal steroids exemplify evidence-based medicine, transforming preterm birth from a dire prognosis to a manageable challenge. Their judicious use, guided by robust data, saves lives across socioeconomic divides.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb